Morgan Stanley
BLEUR

Morgan Stanley’s bleuacacia ltd Rights BLEUR Stock Holding History

Morgan Stanley’s Portfolio BLEUR Stock Details BLEUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed – – 8011
2023
Q4 		$0 Hold
1
– – ﹤0.01% 7932
2023
Q3 		$0 Hold
1
– – ﹤0.01% 7721
2023
Q2 		$0 Hold
1
– – ﹤0.01% 7712
2023
Q1 		$0 Buy
+1
New – ﹤0.01% 7857

Other funds holding BLEUR

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
PL
Parkwood LLC Cleveland, Ohio $1.13B AUM 32.89% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Morgan Stanley's BLEUR Position: Q1 2024 in Review

Morgan Stanley sold out of bleuacacia ltd Rights (BLEUR) in Q1 2024, closing a stake of 1 share.

Morgan Stanley first reported a position in BLEUR in Q1 2023 and held it in 4 quarters. The position peaked at $0 in Q4 2023. 46 funds tracked by Wall St. Rank hold BLEUR as of Q1 2024.

  • Morgan Stanley reported no remaining bleuacacia ltd Rights position as of Q1 2024 after selling out during the quarter.
  • Morgan Stanley sold 1 bleuacacia ltd Rights share in Q1 2024.
  • Morgan Stanley first reported a position in bleuacacia ltd Rights in Q1 2023 and held it in 4 quarters.
  • Morgan Stanley's bleuacacia ltd Rights position peaked at $0 in Q4 2023.
  • 46 funds tracked by Wall St. Rank held bleuacacia ltd Rights as of Q1 2024.

Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.